Luvox®
Back to Test Catalogue
Fluvoxamine (LC-MS/MS), Serum/Plasma
Test ID: FLUVOX SP
Test
Aliases/Synonyms
Method
High Performance Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
Report Includes
Fluvoxamine
Specimens
Avoid gel separator tubes Serum (Preferred); Plasma (Acceptable)
Test Location
NMS Labs, California USA
Test Version
23-Mar-2023
Specimen
Specimens
Avoid gel separator tubes Serum (Preferred); Plasma (Acceptable)
Collection Containers
Preferred
Red top (no additive)
Acceptable
Lavender top (EDTA)
Sample Volume
1 mL
Minimum Volume
0.4 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | Not Stable |
|---|---|
| Refrigerated | 30 days |
| Frozen | 90 days |
Rejection Criteria
| Specimen | Gel-separator tubes or Room Temp. |
|---|
Test Version
23-Mar-2023
Performance / Interpretation
Method
High Performance Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
Turnaround Time
10 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Fluvoxamine | ng/mL |
|
||
|
Steady-state plasma levels following a daily regimen
of 150 to 300 mg/day: 78-920 ng/mL (mean 510) Reporting limit: 10 Test performed at: NMS Labs, 200 Welsh Rd, Horsham, PA 19044-2208 |
||||
Test Location
NMS Labs, California USA
Test Version
23-Mar-2023
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| FLUVOX SP | 64805FLUVOXAMINE, SERUM/PLASMA | ng/mL |
Test Version
23-Mar-2023